The largest trial to date testing adjuvant therapy in breast cancer has found that, contrary to National Cancer Institute recommendations, tamoxifen can likely be continued beyond 5 years. Medscape Medical News
Among patients with stage 4 non-small-cell lung cancer who were positive for EGFR mutations, erlotinib was shown to increase overall survival. Medscape Medical News
Recent media stories about the lack of benefit derived from breast self-examination tended to omit important information and were based on an old review. Medscape Medical News
In a phase 2 trial, an immunotherapeutic given after surgery for lung cancer reduced the risk for relapse to the extent seen with chemotherapy. Medscape Medical News
Early human trials demonstrate safety and feasibility and hint at efficacy in multiple sclerosis and amyotrophic lateral sclerosis. Medscape Medical News
